AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Tocira 80 Infusion

Prescription Icon
Prescription Required

Marketer

Hetero Healthcare Limited

Salt Composition

Tocilizumab (80mg)

Overview Tocira 80 Infusion

Tocilizumab 80mg intravenous infusion treats diverse inflammatory disorders affecting joints (rheumatoid, psoriatic, and ankylosing spondylitis), skin (psoriasis), and intestines (ulcerative colitis, Crohn's disease). Its mechanism involves TNF-alpha inhibition, reducing inflammation. Administration is strictly by a healthcare provider; self-injection is prohibited. Consistent, daily dosing maximizes efficacy. Follow your physician's prescribed regimen diligently, completing the entire course even with symptom improvement. Common adverse reactions encompass headache, hypertension, upper respiratory infections, elevated liver enzymes, and nasopharyngitis. Report persistent or bothersome side effects to your doctor; management strategies are often available. Increased infection susceptibility is a potential risk. Immediately report any infection signs (fever, cough, rash, diarrhea, influenza-like symptoms). Prior to treatment, disclose any pre-existing cardiac, renal, or hepatic issues, and all concurrent medications. Regular blood tests may be conducted to monitor blood cell counts during therapy. Pregnant or breastfeeding individuals should consult their doctor before commencing treatment.

Uses of Tocira 80 Infusion

Management strategies for ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease.

Major Benefits of Tocira 80 Infusion:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Tocira 80 Infusion:

  • Headache
  • High blood pressure
  • Upper respiratory tract infection
  • Injection site reactions (pain, swelling, redness)

How to use Tocira 80 Infusion:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

How Tocira 80 Infusion works:

Tocira 80 Infusion inhibits specific inflammatory mediators, thereby reducing the swelling, redness, and inflammation characteristic of some arthritic conditions.

SAFETY ADVICE

AlcoholAlcoholSAFE

Tocira 80 Infusion may be taken with alcohol without adverse reactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tocira 80 Infusion during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. Your physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Based on limited available data in humans, Tocira 80 Infusion is likely safe for use while breastfeeding; it appears to pose minimal risk to the infant.

DrivingDrivingUNSAFE

Tocira 80 Infusion can cause drowsiness, blurred vision, and dizziness. Driving is discouraged if these effects are experienced.

KidneyKidneyCAUTION

Use of Tocira 80 Infusion requires caution in individuals with impaired kidney function, potentially necessitating dosage modification. Consult your physician for guidance. Data regarding Tocira 80 Infusion's use in patients with moderate to severe kidney disease is limited. Dosage alteration is unnecessary for those with mild kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should receive Tocira 80 Infusion with close monitoring; dosage modifications may be necessary. Physician consultation is advised. Tocira 80 Infusion is contraindicated in individuals experiencing active hepatic disease.

What if you forget to take Tocira 80 Infusion :

Should you forget a Tocira 80 Infusion dose, contact your physician for guidance.

Facts to Know About Tocira 80 Infusion

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Action class Biologic Disease-Modifying Antirheumatic Drugs (bDMARDs)

FAQs on Tocira 80 Infusion

Tocilizumab 80mg infusion is indicated for moderate-to-severe COVID-19 patients with persistent, worsening hypoxia despite 24–48 hours of corticosteroids and supportive care.
Tocira 80 Infusion isn't suitable for all COVID-19 patients due to potential adverse effects. It may prolong infection and viral shedding, therefore administration should only proceed when the benefits clearly surpass the risks.
Tocira 80 Infusion may cause serious side effects such as anaphylaxis (severe allergic reaction), transaminitis (elevated liver enzymes), leukopenia (low white blood cell count, increasing infection risk), and neutropenia (low neutrophil count, impairing infection fighting). Additionally, serious bacterial and viral infections, and tuberculosis reactivation are possible.
Tocira 80 Infusion is contraindicated in patients with a history of abnormal liver enzymes (transaminitis), low platelet counts (<50,000), tuberculosis, or any active bacterial or viral infection. Its use is also prohibited during pregnancy and breastfeeding due to the risk of serious complications.
If your condition doesn't improve after Tocira 80 Infusion, your doctor will determine the next steps. Tocira 80 Infusion reduces lung inflammation but doesn't repair pre-existing damage; lung recovery takes time. Continued shortness of breath warrants further investigation for other lung problems (like pulmonary intravascular coagulopathy) or heart issues (cardiac dysfunction). Any concurrent bacterial infections will require separate treatment.
Tocira 80 Infusion
8,761